We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADCT ADC Therapeutics SA

0.00 (0.0%)
Dec 04 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Share Name Share Symbol Market Stock Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.0% 1.11 18:00:00
Open Price Low Price High Price Close Price Previous Close
Trades Shares Traded Average Volume 52 Week Range
0 0 - 0.359908 - 5.75
Last Trade Type Quantity Price Currency
- 0 US$ 1.11 USD

ADC Therapeutics SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
89.51M 80.64M - 209.91M -155.8M -1.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ADC Therapeutics News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ADCT Message Board. Create One! See More Posts on ADCT Message Board See More Message Board Posts

Historical ADCT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.7251.17370.68830.981601704,1860.38553.1%
1 Month0.80351.17370.3599080.7452552447,6100.306538.15%
3 Months1.001.17370.3599080.7799552338,0920.1111.0%
6 Months2.492.640.3599081.33399,220-1.38-55.42%
1 Year3.635.750.3599082.44552,415-2.52-69.42%
3 Years33.3337.820.3599089.90360,707-32.22-96.67%
5 Years30.0056.58990.35990812.75338,668-28.89-96.3%

ADC Therapeutics Description

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |